---
figid: PMC9467758__OMCL2022-9029544.002
pmcid: PMC9467758
image_filename: OMCL2022-9029544.002.jpg
figure_link: /pmc/articles/PMC9467758/figure/fig2/
number: Figure 2
figure_title: ''
caption: CBR-5884 increases cell ROS level in epithelial ovarian cancer cell lines.
  (a) LDH release, (b) NADPH, (c) GSH, and (d) ROS level of A2780, OVCAR3, and ES-2
  cells after treatment of different concentration of CBR-5884.
article_title: PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression
  via ROS/Wnt/Î²-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib.
citation: Xiaocui Zhang, et al. Oxid Med Cell Longev. 2022;2022:9029544.
year: '2022'

doi: 10.1155/2022/9029544
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
